RUA Life Sciences (FRA:AOHA) EBIT per Share : €-0.09 (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is RUA Life Sciences EBIT per Share?

RUA Life Sciences's EBIT per Share for the six months ended in Mar. 2024 was €-0.02. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.09.

During the past 3 years, the average EBIT per Share Growth Rate was 13.00% per year. During the past 5 years, the average EBIT per Share Growth Rate was -8.30% per year. During the past 10 years, the average EBIT per Share Growth Rate was -7.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for RUA Life Sciences's EBIT per Share or its related term are showing as below:

FRA:AOHA' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -144.8 Med: 10.9 Max: 52
Current: 13

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of RUA Life Sciences was 52.00% per year. The lowest was -144.80% per year. And the median was 10.90% per year.

FRA:AOHA's 3-Year EBIT Growth Rate is ranked better than
59.2% of 723 companies
in the Medical Devices & Instruments industry
Industry Median: 6.4 vs FRA:AOHA: 13.00

RUA Life Sciences's EBIT for the six months ended in Mar. 2024 was €-0.68 Mil.

RUA Life Sciences EBIT per Share Historical Data

The historical data trend for RUA Life Sciences's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RUA Life Sciences EBIT per Share Chart

RUA Life Sciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT per Share

Get a 7-Day Free Trial

-0.07

-0.10

-0.13

-0.12

-0.07

RUA Life Sciences Semi-Annual Data
	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
EBIT per Share	Get a 7-Day Free Trial															-0.06	-0.06	-0.06	-0.07	-0.02

RUA Life Sciences EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

RUA Life Sciences's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

	EBIT per Share		(A: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-2.264	/	33.547
=	-0.07

RUA Life Sciences's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.675	/	44.908
=	-0.02

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.09

RUA Life Sciences (FRA:AOHA) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

RUA Life Sciences EBIT per Share Related Terms

Thank you for viewing the detailed overview of RUA Life Sciences's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

RUA Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » RUA Life Sciences PLC (FRA:AOHA) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

RUA:UK

Address

2 Drummond Crescent, Ayrshire, Scotland, Irvine, GBR, KA11 5AN

Website

https://www.rualifesciences.com

RUA Life Sciences PLC is a biomedical polymer technology, components, and medical device company. The company's principal activities comprise exploiting the value of its IP and know-how, medical device contract manufacturing, and development of cardiovascular devices. Its business segments are Royalty and License Income (Biomaterials), Contract Manufacture, Product Development (Vascular), and Product Innovation (Structural Heart). It derives the majority of its revenue from the Contract Manufacture segment. Geographically, it derives the majority of its revenue from the USA and has a presence in Switzerland, Italy, the UK, and Israel.

RUA Life Sciences Headlines

No Headlines